These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. The Alzheimer's disease mitochondrial cascade hypothesis: an update. Swerdlow RH; Khan SM Exp Neurol; 2009 Aug; 218(2):308-15. PubMed ID: 19416677 [TBL] [Abstract][Full Text] [Related]
6. Alzheimer's Disease is Driven by Intraneuronally Retained Beta-Amyloid Produced in the AD-Specific, βAPP-Independent Pathway: Current Perspective and Experimental Models for Tomorrow. Volloch V; Olsen B; Rits S Ann Integr Mol Med; 2020; 2(1):90-114. PubMed ID: 32617536 [TBL] [Abstract][Full Text] [Related]
7. Synaptic Mitochondria: An Early Target of Amyloid-β and Tau in Alzheimer's Disease. Torres AK; Jara C; Park-Kang HS; Polanco CM; Tapia D; Alarcón F; de la Peña A; Llanquinao J; Vargas-Mardones G; Indo JA; Inestrosa NC; Tapia-Rojas C J Alzheimers Dis; 2021; 84(4):1391-1414. PubMed ID: 34719499 [TBL] [Abstract][Full Text] [Related]
8. Biomarkers, ketone bodies, and the prevention of Alzheimer's disease. VanItallie TB Metabolism; 2015 Mar; 64(3 Suppl 1):S51-7. PubMed ID: 25468143 [TBL] [Abstract][Full Text] [Related]
11. The mitochondrial secret(ase) of Alzheimer's disease. Young KJ; Bennett JP J Alzheimers Dis; 2010; 20 Suppl 2():S381-400. PubMed ID: 20442493 [TBL] [Abstract][Full Text] [Related]
12. Amyloid accumulation is a late event in sporadic Alzheimer's disease-like pathology in nontransgenic rats. Stefanova NA; Muraleva NA; Korbolina EE; Kiseleva E; Maksimova KY; Kolosova NG Oncotarget; 2015 Jan; 6(3):1396-413. PubMed ID: 25595891 [TBL] [Abstract][Full Text] [Related]
13. An agnostic reevaluation of the amyloid cascade hypothesis of Alzheimer's disease pathogenesis: The role of APP homeostasis. Caselli RJ; Knopman DS; Bu G Alzheimers Dement; 2020 Nov; 16(11):1582-1590. PubMed ID: 32588983 [TBL] [Abstract][Full Text] [Related]
14. Exploring the Potential of Therapeutic Agents Targeted towards Mitigating the Events Associated with Amyloid-β Cascade in Alzheimer's Disease. Behl T; Kaur I; Fratila O; Brata R; Bungau S Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33050199 [TBL] [Abstract][Full Text] [Related]
15. Inhibitory effects of curcumin on H Song XJ; Zhou HY; Sun YX; Huang HC Mol Biol Rep; 2020 Mar; 47(3):2047-2059. PubMed ID: 32036572 [TBL] [Abstract][Full Text] [Related]
17. Precursor-Independent Overproduction of Beta-Amyloid in AD: Mitochondrial Dysfunction as Possible Initiator of Asymmetric RNA-Dependent βAPP mRNA Amplification. An Engine that Drives Alzheimer's Disease. Volloch V; Olsen BR; Rits S Ann Integr Mol Med; 2019; 1(1):61-74. PubMed ID: 31858090 [TBL] [Abstract][Full Text] [Related]
18. Mitochondria, mitochondrial DNA and Alzheimer's disease. What comes first? Mancuso M; Orsucci D; Siciliano G; Murri L Curr Alzheimer Res; 2008 Oct; 5(5):457-68. PubMed ID: 18855587 [TBL] [Abstract][Full Text] [Related]
19. Brain Aging and Late-Onset Alzheimer's Disease: A Matter of Increased Amyloid or Reduced Energy? Mecocci P; Baroni M; Senin U; Boccardi V J Alzheimers Dis; 2018; 64(s1):S397-S404. PubMed ID: 29562513 [TBL] [Abstract][Full Text] [Related]
20. The Alzheimer's Disease Mitochondrial Cascade Hypothesis: A Current Overview. Swerdlow RH J Alzheimers Dis; 2023; 92(3):751-768. PubMed ID: 36806512 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]